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Abstract 
The Diels-Alder reaction is a keystone reaction in synthetic chemistry. It is used 
extensively in the preparation of pharmaceuticals, crop protection agents and 
commodity chemicals. Diels-Alder biocatalysts offer expedient, green routes to a vast 
array of useful molecules, however, the development of industrially relevant Diels-
Alderases has been hampered by their unsuitability for use at extremes of 
temperature, pressure and pH and their incompatibility with organic solvents. In this 
study a two-step polymer surfactant conjugation method has been developed, 
optimised and applied to the natural Diels-Alderase AbyU. This method involves the 
modification of protein surfaces through chemical super-charging, followed by 
polymer surfactant conjugation to form an amphipathic surfactant corona. The 
resulting AbyU-polymer conjugates exhibit increased tolerance to ‘harsh’ reaction 
conditions and enhanced catalytic efficiency versus the wild type enzyme. These data 
support the value of the outlined conjugation approach as a general method for 
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Chapter 1. Introduction  
An important part of the drive towards environmentally friendly, green chemical 
synthesis is a reduction in the use of synthetic catalysts, and their substitution with 
enzymes (Turner & Truppo, 2013). Enzyme-based biocatalytic processes offer a 
highly selective, safe, and sustainable route to the scalable production of a multitude 
of important molecules (Truppo, 2017). Unlike many chemical catalysts, biocatalysts 
often exhibit exquisite enantio- and stereoselective control of the reactions that they 
perform, offering expedient routes to the assembly of complex molecules that present 
a challenge to conventional synthetic methodology (Choi, Han, & Kim, 2015). Through 
protein engineering, enzymes can be modified to change their properties, for example 
to enable the selection and transformation of ‘non-natural’ substrates, or to make them 
compatible with specific industrial processes or reaction conditions (Renata, Wang, & 
Arnold, 2015). Furthermore, enzymes are produced from low cost renewables, and 
are inherently biodegradable. Enzymes therefore offer an efficient means to produce 
a homogenous pool of active molecules, through iterative rounds of reaction cycles 
before degradation (de Regil & Sandoval, 2013). Biocatalysts that perform carbon-
carbon bond forming reactions are particularly highly sought after, as they enable 
atom-efficient, enantioselective assembly of complex organic scaffolds to produce 
active versions of important compounds such as pharmaceuticals, crop protection 
agents and commodity chemicals (Schmidt, Eger, & Kroutil, 2016).  
The need for powerful biocatalysts is exemplified in the pharmaceutical industry. The 
demand for new antibiotics has become a pressing problem in recent years. Antibiotics 
have revolutionised modern medicine, however, resistance acquisition continues to 
outpace antibiotic development (SMAC, 1998). Resistance selection is an inevitable 
consequence of antibiotic use, therefore the development for new antibiotics with 
diverse, or ideally new, modes of action is urgently needed. Natural products 
represent a leading source for drug candidates, especially antibacterial agents 
(Dias, Urban, & Roessner, 2012). For example, pioneering research in the 1940s 
into the anti-bacterial mechanisms of microbes, led to the discovery of streptomycin 
(Hughes & Karlén, 2014). Currently, research has also explored the production of 
new drugs from the metabolites of microbes (Ruiz, et al., 2010), through the 
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refinement of natural enzymes that have evolved to produce them. Therefore, 
modifying natural enzymes, for example through directed evolution or genetic 
approaches, represents a promising method for enabling access to new antibiotics, 
via the production of ‘non-natural’ natural products (Chandra Mohanaa, et al., 2018).  
Microorganisms which exist under extreme environmental conditions are likely to 
yield unique and powerful bioactive compounds, to which resistance has not yet 
emerged (Subramani & Aalbersberg, 2012). It is posited that exposure to such 
‘extreme’ conditions drives the acquisition of metabolic innovations, which in turn 
translates into the production of novel bioactive natural products. Verrucosispora 
maris, a deep-sea bacterium which lives on the Pacific seabed (Goodfellow, et al., 
2012), produces a family of polycyclic antibiotics which include abyssomicin C (Figure 
1.1). Enzymes involved in the biosynthesis of this compound are the focus of the 
research outlined in this thesis. Abyssomicin C shows antibiotic activity against Gram-
positive bacteria including pathogenic strains of methicillin resistant Staphylococcus 
aureus (MRSA) (Riedlinger, et al., 2004). It has a unique mode of action, targeting the 
bacterial folate biosynthesis pathway, the product of which is required for DNA 
processing and maintenance. This pathway is absent in humans, minimising the 
possibility of off target effects and improving the likelihood of clinical viability.  
Abyssomicin C is biosynthesised by a Type I modular polyketide synthase (PKS) 
pathway (Figure 1.1). Polyketides are a functionally diverse class of molecules bearing 
clinically relevant pharmacological activities, for example the anticancer agent 
Epothilone (Osswald, et al., 2014) and the antibiotic Erythromicin (Vieweg, Reichau, 
Schobert, Leadlay, & Süssmuth, 2014). The enzyme AbyU acts during the later stages 
of abyssomicin C biosynthesis, where it catalyses an enantiomerically-selective formal 
Diels-Alder reaction to yield a spirocyclic product from a linear polyketide substrate 
(Byrne, et al., 2016). It has been proposed that modification of AbyU could offer a route 
to the production of functionally optimised abyssologues, with improved clinical 
performance as compared to the native natural product. Significantly, this work 
unlocks a wealth of options for making new bioactive compounds that could form the 







Figure 1.1 Proposed abyssomicin C biosynthetic pathway. The multi-modular PKS 
complex (AbyB1-3) biosynthesises a linear polyketide product, which is coupled to an ACP-
tethered C3 precursor, which originates from 1,3-bisphosphoglycerate. The linear polyketide 
1, is condensed with the C3 unit covalently attached to the free-standing thiolation domain 
AbyA3 to form the five-membered tetronate ring of 2. This compound is subsequently 
acetylated by AbyA4, followed by an AbyA5 catalysed acetate elimination. These steps install 
the distinctive exocyclic methylene group of 3. An enzyme catalysed intramolecular Diels–
Alder, performed by the enzyme AbyU, then takes place between the exocyclic methylene of 
3 and a diene present in the conjugated triene system of 3, generating the 
spirotetronate nucleus of atrop-abyssomicin C in 4.  Tailoring macrocyclic 4 gives abyssomicin 
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1.1 The Diels-Alder Reaction 
In a Diels-Alder reaction, an unsaturated hydrocarbon containing two C=C bonds (the 
diene), reacts with a dienophile, which is usually an electron-poor alkene group or 
alkyne group (Figure 1.2). This is an example of a [4+2] cycloaddition, in which one 
reactant molecule contributes four π electrons and the other two π electrons to yield 
a [4+2] cycloadduct.  
 
          
 
 
       Diene     Dienophile    Diels Alder Adduct 
Figure 1.2 The Diels-Alder reaction.  Adapted from Cyclic Dienes and Dienophiles in the 
Diels-Alder Reaction (Chemistry, 2018). Black curly arrows represent the movement of 
electrons.   
The Diels-Alder reaction is thermally sensitive. Heat will favour the forward reaction, 
whilst high heat will favour thermal decomposition of the covalent bonds formed 
between the diene and dienophile, through the retro-Diels–Alder reaction (Liu, Hsieh, 
& Chen, 2006). Diels-Alder reactions also respond to adjustments in pressure, 
allowing many factors to be optimised to increase yield. A major obstacle for the use 
of biocatalysts in organic synthesis is their thermodynamic and kinetic instability under 
harsh reaction conditions. Since industrial processes often involve high temperature 
reactions and extreme pressure, modification of enzymes to confer improved 
tolerance to these conditions is invaluable.   
Bonds formed  
 
C1 – C6 
C2 – C3 (p) 




Bonds broken  
 
C1 – C2 (p) 
C3 – C4 (p) 













1.2 Structure of the Natural Diels-Alderase AbyU  
The abyssomicin C precursor is a macrocyclic spirotetronate, which comprises a 
tetronic acid ring spiro-linked to cyclohexene. This compound has recently been 
shown to be produced by a Diels-Alder reaction, catalysed by the enzyme AbyU 
(Byrne, et al., 2016). The AbyU core adopts a distinctive b-barrel fold. A flexible loop 
(residues Asp26-Gly36 between sheets b1 and b2) is believed to regulate entry and 
exit of the enzyme’s active site cavity (Figure 1.3). Based on molecular modelling 
studies of the enzyme in complex  with its substrate, the majority of interactions 
between residues in the enzyme active site and the cognate AbyU substrate are 
hydrophobic in nature, with a solitary hydrogen bond predicted between a substrate 
carbonyl and the side chain of Tyr76 (Byrne, et al., 2016).  
Figure 1.3 Schematic of the AbyU catalysed Diels-Alder reaction. (Hashimoto & 
Kuzuyama, 2016).  
AbyU is a dimer in solution. The internal channel of each barrel monomer is book-
ended by a salt bridge formed between the residues Glu19 and Arg122 and a 
predominantly hydrophobic loop which joins β1 to β2 (Figure 1.4).  AbyU-catalysed 
bond formation (2x C-C bonds) occurs concerted, albeit asynchronous manner, via 
resolution of the energetically favourable transition state. The shape of the enzyme 
active site optimally matches that of the transition state of the reaction. This allows the 
bond formation to proceed with a low free-energy barrier (Byrne, et al., 2016).  








Figure 1.4 (A) Crystal structure of the AbyU dimer, coloured by 2° structure (b structure in 
green, a structure in blue and flexible loops in pink). The substrate mimic HEPES is observed 
in the enzyme active site and is shown in stick format. (B) Docking simulation of the 
conformation of the AbyU product (cyan carbons), overlaid with the equivalent poses of the 
docked substrate (orange carbons) and the intermediate product (magenta carbons) in the 
AbyU active site. Active site residues Phe41 and Trp124 are indicated for reference (green 
carbons). Adapted from Byrne, et al. 2016. 
To date, nine gene clusters of spirotetronate antibiotics have been identified, all of 
which possess AbyU-like putative Diels-Alderases (Zheng, et al., 2016). In addition, 
the large number of natural products that contain [4+2] adducts suggests the existence 
of many more natural enzymes that can catalyse Diels-Alder reactions. In contrast to 
de novo designed Diels-Alderases, whose active sites are derived from computational 
models based on a set of existing protein scaffolds (Preiswerk, et al., 2014), and which 
can only act upon simple substrates, most natural [4+2] adducts have complex 
structures. Therefore, modification of natural Diels-Alderases is likely to provide a 
route to a multitude of increasingly complex bioactive chemical architectures. 
Conversely, naturally evolved Diels-Alder biocatalysts represent attractive frameworks 
for directed evolution to develop industrially relevant enzymes for this reaction. 
 
A B  














1.3 Modification of AbyU  
An obstacle to the utility of AbyU is that its substrate and product, although miscible in 
water, require organic solvents to help dispersion and prevent aggregation. This is a 
direct consequence of the distinctive C3 carbon tail present in the molecule. However, 
if the enzyme were modified appropriately, it could be active in a solvent-free state, 
making it much more useful in industrial applications. An example of such a 
modification is protein bioconjugation. Conjugation aims to chemically couple a 
biomolecule with other molecules to form stable conjugates, resulting in the combined 
properties of the constituent components or enhanced properties from synergistic 
effects (Hermanson, Bioconjugate techniques, 1996). Once assembled, these 
conjugates may be used for a broad variety of applications, for example therapeutics, 
imaging probes or as a catalytic system (Hermanson, PEGylation and Synthetic 
Polymer Modification, 2013). Several techniques are reported in the literature that 
involve crosslinker and modification reagents, and include, for example, PEGylation; 
the attachment of polyethylene glycol (PEG) to proteins.  This can endow desirable 
attributes such as improved water solubility and thermal stability (Zalipsky, 1995).  The 
bioconjugation methods employed in the work outlined in this thesis is a two-step 
protocol that involves cationisation, which introduces a positive charge to the protein 
surface, followed by surfactant conjugation and the attachment of a synthetic polymer 
to the outside of the charged protein. The enzyme can then be lyophilised and freeze-
dried, allowing it to be taken it out of aqueous solution whilst retaining its function 







Enzyme cationisation is a well-established bio-conjugation technique in which the 
acidic amino acids aspartate and glutamate on the protein surface are bonded to 
amines, creating a positively charged cross-linked protein. To perform cationisation, a 
cross-linking agent that contains reactive termini able to attach to functional groups is 
often required (Farkaš & Bystrický, 2010). Potential functional groups include primary 
amines (–NH2), which are found at the N-termini of proteins, or carboxyl groups (–
COOH), at the C-termini of polypeptide chains. Classical strategies employed in 
chemical coupling include; reductive amination, where free aldehydes (-CHO) and 
ketones (RC(=O)R') are reacted with amines; amide bond formation; and activation 
of hydroxyl (-OH) groups (Montalbetti & Falque, 2005). Preferential conjugation with 
amines represents one of the most used widely reactions to introduce linkers to 
biomolecules, and results in amide bond formation (Montalbetti & Falque, 2005). 
This requires a preparative step turning the carboxylic acid into an active ester. 
Carbodiimide-based activation of carboxyl groups, as employed in this study, is the 
most commonly used method for active ester preparation (Warhi & Al-Hazimi, 2012), 
with N-substituted carbodiimides widely used in bioconjugate chemistry,  specifically 
1-ethyl-3-(-3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) (Grabarek & 
Gergely, 1990) (Figure 1.5). This agent forms active esters in a single step and was 
chosen to be used in this study due its compatibility with biomacromolecules including 




Figure 1.5 Chemical structures of the cationising agents, N,N-dimethyl, 1-,3-
propendiamine (DMPA) and EDC.  
DMPA, 102.18 g.mol
-1




Cationisation has many advantages over alternative bioconjugation methods. 
Significantly, the addition of negatively charged compounds or particles through 
electrostatic interactions does not disrupt the quaternary structure of target proteins. 
Enzyme supercharging has already been shown to improve folding robustness and 
impart aggregation resistance, without abolishing enzyme function (Lawrence, 
Phillips, & Liu, 2007). For example, it has been extremely successful with other 
proteins, such as green fluorescent protein (GFP), as extensively mutating the surface 
of a protein to enhance their overall charge was seen to enhance thermodynamic 
stability (Strickler, et al., 2006). In this study cationisation is used to attach a negatively 
charged surfactant polymer to the protein AbyU, to enable the assembly of a 
sophisticated protein-based biomaterial (Armstrong, et al., 2015). Modification of 
protein surfaces is achieved by coupling of N,N-dimethyl, 1-,3-propendiamine (DMPA) 
to aspartate and glutamate side chains using EDC (Correia Carreira, 2017) (Figure 
1.6). DMPA is added to the solution first, and the reaction is started with the presence 
of EDC in the solution. EDC covalently attaches to the protein and catalyses charge 
switching by activating the protein carboxyl groups. DMPA amidates the activated 
carboxylic acids, covering the protein surface in positive charge. This is highly pH 
dependent, since an acidic pH protonates amine groups of DMPA. Furthermore, the 
theoretically calculated isoelectric point of AbyU (based on amino acid composition) is 
pH 5.5, hence pH must be closely monitored to prevent protein precipitation. It has 
also been shown that EDC will coat the protein with 90% efficiency between pH’s 4 




Figure 1. 6 Carboxyl-to-amine crosslinking involving the use EDC. Molecules 6 and 7 are 




















































In AbyU, the majority of the polar amino acids reside on the outside of the protein 
(Figure 1.7). This is important as it means cationisation is unlikely to affect the enzyme 
active site, and thus negatively impact the ability of the enzyme to catalyse the Diels-
Alder reaction. It should be noted that changes in surface electrostatics resulting from 
supercharging could destabilise the protein structure, however, the total volume of the 
internal volume of the AbyU active site is limiting and is likely to cause too much steric 
hindrance as to allow the DMPA molecule to assume the correct geometry for 
attaching to the acidic residues within the active site. Therefore, techniques to study 
protein folding, such as circular dichroism (CD) spectroscopy, will need to be 










Figure 1.7 Structures of AbyU. (A) Negatively charged aspartic and glutamic acid residues 






The directed modification of polypeptides via bio-conjugation has proven a useful 
technique to improve natural systems and generate therapeutic protein constructs 
(Spicer & Davis, 2014). Here, conjugation describes the addition of the surfactant 
polymer IGEPAL-890, to the outer surface of the enzyme, AbyU, via electrostatic 
interactions forming a “corona” or outer shell (Figure 1.8). This particular reaction, 
using an anionic surfactant, has found considerable applications in organic synthesis, 
materials chemistry and for the bioconjugation of larger constructs (Brogan & Hallet, 
2016). The polymer IGEPAL-890 was chosen due to its hydrophobic nonylphenyl tail, 
which has been shown to facilitate persistent membrane affinity (Armstrong, et al., 
2015). This is desired, for example, to create a surface-functionalised Diels-Alder 
system or for extending the shelf life of AbyU by partitioning it into liposomes. The 
polyethylene oxide structure has also been shown to prevent protein denaturation, 
which is highly useful for application in industrial processes (Armstrong, et al., 
2015). The primary alcohol (hydroxyl) group of the surfactant, IGEPAL-890 is oxidised 







Figure 1.8 Carbodiimide-mediated cationisation of AbyU. A glutamic acid side-chain of 
native AbyU, [N-AbyU], is modified by N,N-dimethyl-1,3-propanediamine (DMPA) to yield 
cationised AbyU, [C-AbyU], followed by electrostatic coupling with oxidised surfactant (S-), to 
give conjugated AbyU, [C-AbyU][S].  
 




















Surfactant polymer  
Native protein, [N-AbyU] 
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A reported effect of conjugation is that it improves enzyme stability, possibly by 
creating an outer-shell casing around the protein that imparts enhanced structural 
integrity (Armstrong, et al., 2015). Furthermore, bio-conjugation of proteins using 
cationisation and electrostatic binding of appropriately charged surfactant polymers 
has been shown to generate a dehydrated pure protein melt upon lyophilisation 
(Perriman, Cölfen, Hughes, Barrie, & Mann, 2009), These conjugates could be used, 
for example, to facilitate membrane insertion, to form membrane micro-bioreactors, 
which have wide applications in environmental treatment, pharmaceutical 
manufacture and energy generation (Chakraborty, et al., 2016). The choice of 
surfactant can direct which solvent an enzyme can be solubilised in. For example, to 
dissolve a protein into a polar solvent, such as acetonitrile, an amphipathic surfactant 
must be selected. Therefore, bio-conjugation offers a route to achieving protein 
stability and catalytic efficiency in non-native media (Tung, C, Fung, & Li, 2016). It has 
been shown previously that surfactant coating can plasticise the structure of proteins 
in a manner analogous to water hydration (Correia Carreira, 2017), allowing it to 
function in non-aqueous solutions. This is significant, as typically this would result in a 
loss of protein flexibility and function, resulting in impairment of protein dynamics. Such 
an effect may manifest in an inability to access the different conformational states 
required by an enzyme for catalytic activity (Fogarty & Laage, 2014). The structure 
and folding of enzyme conjugates must therefore be investigate using appropriate 
biophysical methods, such as circular dichroism (CD) spectroscopy, in order to 







1.6 Research Aims 
The ambition of this project was to apply bioconjugation methods to the natural Diels-
Alderase AbyU, to generate polymer conjugated variants of this industrially relevant 
enzyme. The resulting protein-polymer conjugates were to be tested for tolerance to 
‘harsh’ reaction conditions, akin to those commonly employed in process chemistry 
workflows. Finally, the impact of conjugation on AbyU catalytic function was to be 
assessed to establish the impact of conjugation of the kinetic properties of AbyU. 
Significantly, this research will lay the foundation for modifying AbyU and related beta-












Chapter 2. Materials and Methods 
2.1 Protein Expression 
10 mL LB containing 100 µg.mL-1 carbenicillin was inoculated with an individual colony 
of E. coli BL21 (DE3) cells pre-transformed with pOPINF::AbyU (gift from Carl Marsh, 
University of Bristol). This inoculum was cultured with shaking at 200 rpm overnight at 
37°C. This culture was transferred to 1 L LB containing 100 µg.mL-1 carbenicillin, which 
was subsequently grown with shaking at 200 rpm at 37°C until an OD600nm of 0.5 was 
obtained. The culture was cold shocked on ice for 15 minutes. Protein expression was 
via the addition of 1 mM IPTG (final concentration). The culture was then grown at 
18°C with shaking at 200 rpm for 18 hours. Cells were recovered by centrifugation at 
4600 g for 25 minutes. Cell pellets were archived at -80°C before being subjected to 
lysis. 
2.2 Protein Preparation 
Cell pellets were defrosted and re-suspended in 40 mL of Load buffer (50 mM Tris-
HCl, 150 mM NaCl, 20 mM imidazole, pH 7.5). Suspensions were lysed by passage 
through a cell disruptor (Constant Systems Ltd). The recovered lysate was clarified by 
centrifuging for 30 minutes at 38,000 g and the supernatant decanted and loaded onto 
a nickel charged 5 mL HisTrap FF column (GE life sciences). Contaminating proteins 
were removed by washing with 8 column volumes of Load buffer. Protein bound to the 
column was eluted over 30 mL using a linear gradient of 0-50% Load to Elute buffer 
(150 mM NaCl, 20 mM Tris-HCl, 1 M imidazole, pH 7.5), collecting 1.5 mL fractions 
throughout the process. Fractions were analysed by absorbance at 280 nm of the 
column eluent followed by SDS-PAGE analysis of recovered fractions. Fractions 
containing AbyU at >70 % purity were mixed and concentrated to 2 mL by 
centrifugation. The resulting pooled protein was applied to a GE Healthcare 16/60 S75 
column, pre-equilibrated in SEC buffer (150 mM NaCl, 20 mM Tris-HCl, pH 7.5). 
Elution was by passage of 120 mL of buffer through the column, with 1.5 mL fractions 
collected from 40–120 mL. Fractions were analysed by absorbance of the column 
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eluent at 280 nm, with fractions subsequently evaluated by SDS-PAGE. Fractions 
estimated to be of >95 % purity were pooled and concentrated to 10 mg.mL-1. 100 µL 
aliquots of this material were flash frozen and archived at -80°C. 
2.3 Protein Modification 
Solutions of recombinant AbyU (2 mg. mL−1) were passed through a 0.22 μm syringe 
filter and then incubated with a 200 mg. mL−1 solution of N,N-dimethyl-1,3-
propanediamine (DMPA) at pH 6, maintained by addition of 6 M HCl in a fume hood. 
The solutions were continuously stirred for 4 h, following which EDC solid was 
added and the sample stirred for an additional 4 h. Aspartic/glutamic acid residues 
in AbyU were cationised using an EDC zero-length crosslinker and DMPA as the 
cationising amine. Generally, the amine was diluted to a concentration 150 times molar 
concentration of the protein and then brought to pH 6 using HCl (6 M), after which it 
was added to a 2 mL solution of AbyU dissolved in 20 mM phosphate buffer. A 34-fold 
excess of EDC. HCl was added, followed by a second addition of this reagent after a 
4 h interval, to maintain the reaction. The protein was subsequently dialysed against 
4 L of 20 mM phosphate buffer (pH 7.5) at 4°C overnight, to produce stable solutions 
of the DMPA-cationised protein, with frequent water changes over a 24-hour period. 
Aggregates were removed using a 0.22 μm filter.  2.5 mL of the dialysed cationised 
protein was loaded onto a Centrisart 10K CTA column. Modified AbyU was eluted from 
the column via passage of 25 mL of buffer through the column under gravity. Protein 
recovery was quantified by UV-vis spectrometry. The degree of cationisation was 
determined using MALDI Time of Flight (ToF) mass spectrometry. [C-AbyU] was 
stored at 4°C following preparation but prior to experimentation.  
The glycolic acid ethoxylate 4-nonylphenyl ether surfactant, IGEPAL CO-890 (Figure 
2.1) was synthesised by the oxidation of the hydroxyl groups of a glycolic acid 
ethoxylate 4-nonylphenyl ether to yield a carboxylic acid terminus. Complexation of 
the anionic polymer surfactant (Figure 2.2) was carried out at a ratio of 1 surfactant 
chain per newly cationised site, to ensure high conjugation efficiency and prevent 
surfactant self-association. The protein solution was stirred for 2 hours with a 
10 mg.mL−1 of oxidised IGEPAL CO-890 in 20 mM of the reauisite buffer at 4 °C. 
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The resulting protein-surfactant solution was centrifuged to remove any aggregates. 
Size exclusion chromatography was carried out to select for protein populations that 
were homogenously conjugated and to remove any excess surfactant. The resulting 
solution was stored at 4 °C. The concentrations of [C-AbyU]and [C-AbyU][S] were 
estimated using a BCA assay and/or Bradford assay.   
 





Figure 2.2 Complexation of oxidised polymer surfactant with cationised protein 
sidechain. The electrostatic interaction between the anionic polymer and positively charged 
coupled diamine is shown as a dashed blue line.  
2.4 BCA Assay  
Serial dilutions of a Bovine Serum Albumin (BSA) standard stock solution (2mg.mL-1) 
were performed as recommended by the manufacturer (ThermoScientific). The total 
















(# standards + # unknowns) × (# replicates) × (volume of WR per sample) = total 
volume WR required  
2 mL of WR is needed per sample. In this case, there were 10 standards, 2 unknowns 
and 3 replicates, requiring 72 mL of WR. The BCA reagents A and B were mixed in a 
50:1 ratio and vortexed to mix well. 25 µL of each sample (standard and unknown) 
was pipetted into a 96-well plate well. 200 µL BCA WR was then pipetted into each 
well of the plate. Plates were then sealed and incubated for 30 minutes at 37 °C, then 
left to cool for 5 minutes. The absorbance of each sample well was determined at 562 
nm using a plate reader (Synergy™ BioTek HTX Multi-Mode Reader). A standard 
graph was generated using the formula y = mx + c.  
2.5 Bradford Assay 
Bradford assays were performed according to a standard assay procedure using 96-
well microarray plate. A 2 mg.mL-1 BSA standard was used and diluted as detailed by 
the manufacturer (Thermofisher). Samples were assayed in triplicate. Blank samples 
were made using Milli Q grade water and dye reagent. Sample solutions, both 
standards and unknowns were pipetted into individual wells. A multichannel pipette 
was used to dispense the 1x dye reagent, with sample mixing achieved by repeated 
pipetting. Samples were incubated for 5 minutes at 20oC and followed by 
measurement of absorbance at 595 nm. 
2.6 Substrate Synthesis  
The AbyU substrate was synthesised and purified by Li-Chen Han of the Willis group, 
School of Chemistry, University of Bristol according to literature syntheses (Byrne et 
al., 2016). The resulting solutions of substrate were purified to a concentration of 60 
mM. Substrate solutions were stored at -80°C to prevent spontaneous cyclisation.  
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2.7 SDS-PAGE  
10 μL protein solutions were heated to 100oC for 10 minutes in 10x sample buffer 
(Thermofisher). 10 μL samples were loaded onto 15% NuSEP Tris–glycine gels. Gels 
were electrophoresed using a Mini Protein II gel apparatus (Bio-Rad) employing Tris–
glycine running buffer at 150 V over 50 minutes. 
2.8 NATIVE-PAGE  
Samples were prepared by mixing equal quantities of protein solution and sample 
buffer (87 mM Tris-HCl, 0.2% bromophenol blue and 0.004% glycerol, 1 mM DTT). 
Samples were then loaded into the wells of a 10% native polyacrylamide gel. Gels 
comprised 375 mM Tris-glycine, pH 8.8 (resolving gel), and 625 mM Tris-glycine, pH 
6.8 (stacking gel). Gels were electrophoresed in running buffer (0.19 M glycine, 25 
mM Tris-HCl, pH 8.8) at 15 V for 150 minutes.  
2.9 Liquid Chromatography-Mass Spectrometry  
Chromatographic separations were performed using a 5 µm C18 100 Å, 4.6 x 250 
LUNA column (Phenomenex), using a linear gradient of 10-90% acetonitrile/0.5% 
formic acid over 15 minutes. Mass spectrometry was performed using a Waters ZQ 
Micromass spectrometer in positive ion mode. Molecular masses were determined b 
mass spectrometry, with the assistance of Li-Chen Han (Chemistry, Bristol).  
2.10 Zeta Potential Measurements 
Cationisation efficiencies were assessed qualitatively using dynamic light scattering 
(DLS) coupled with zeta potential measurements, with protein samples at 1 mg.mL-1 
final concentration using a Malvern Nano-Z instrument. An average of 100 runs per 
sample were collected and averaged. The zeta potential of the 20 mM phosphate 
buffer at pH 7 [-10 mV] was determined and subtracted from final zeta potential 
measurements. Cationisation was verified by a change in zeta potential. It is expected 
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that the zeta potential will become more positive once the protein has been cationised 
due to an increase in surface electrostatics. Following conjugation, the zeta potential 
should return to ~0 mV, since the surfactant will have attached to the positively 
charged amino acids on the protein surface.  
2.11 Matrix-Assisted Laser Desorption / Ionisation Mass 
Spectrometry (MALDI-MS) 
Molecular masses of native and cationised proteins were measured using MALDI-MS 
using an Applied Biosystems 4700 Proteomics Analyser). Mass spectroscopy enabled 
calculation of the average number of DMPA (MW 100 Da) molecules bound per 
cationised protein molecule. Non-cationised AbyU was used as the background 
control. Each 100 Da increase in mass has taken to corelate to the addition of a single 
molecule of DMPA. For example, a mass increase of ~500 Da detected after 
cationisation was taken as equating to the addition of 5 DMPA molecules. Porcine 
trypsin (Sequencing-grade, Promega) was dissolved in 50 mM acetic acid, followed 
by 5-fold dilution, achieved by adding 25 mM ammonium bicarbonate. The final 
concentration of trypsin used was 0.02 µg.µL-1. 10 µL of this protease solution was 
mixed with each protein sample, followed by incubation at 37 °C overnight. 1 µL 
aliquots of each digest preparation was applied to the ground steel MALDI target plate, 
with this application followed immediately with an equal volume of 4-hydroxy-a-cyano-
cinnamic acid (freshly-prepared, 5 mg.mL-1, Sigma Aldrich) suspended in 50% 
aqueous (v/v) acetonitrile, supplemented with 0.1%, trifluoroacetic acid (v/v). Analyses 
were performed using a Bruker ultraflex III MALDI mass spectrometer in positive-ion 
mode, fitted with a Nd:YAG smart beam laser. All spectra were acquired over a mass 
range of m/z 800-4000 using FLEX Control software (Bruker, USA) and peaks were 
identified using FLEX Analysis software (Bruker, USA).  
2.12 Tryptic Digest 
For tryptic digest analysis of proteins, 20 μg samples of the cationised AbyU 
polypeptide were added to 80 μL of 20 mM Tris-HCl, pH 8. 5 μL of 200 mM TCEP was 
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added followed by incubation at 55 °C for 1 hr. 10 μL of a 400 mM iodoacetamide 
stock solution was added to the buffered protein solution, which was then incubated 
for 1 hr at 25 oC. Following incubation 10 μL of 400 mM DTT was added and samples 
were incubated at RT for a further 1 hr. 1 μg Trypsin was added to solution and a final 
incubation at 37 °C overnight performed. The digested sample was resuspended in 
5% formic acid followed by desalting on a SepPak cartridge (Waters).  The eluate from 
the cartridge was evaporated and resuspended in 1% formic acid in preparation for 
nano-LC MS/MS analysis. Samples were fractionated using an Ultimate 3000 nano-
LC system fitted with an LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific).  
Peptides in 1% (vol/vol) formic acid were next loaded onto a  250 mm × 75 μm Acclaim 
PepMap C18 nano-trap column (Thermo Scientific) which was then washed with 0.5% 
(vol/vol) acetonitrile 0.1% (vol/vol) formic acid. Peptides purification was performed 
using a previously reported standard regime (Fu et al., 2017). Solvent A comprised 
0.1% formic acid; Solvent B comprised 80% acetonitrile with 0.1% formic acid.  
Resolved peptides were ionized using nano-electrospray ionization at 2.1 kV 
employing a 30 μm diameter stainless-steel emitter (Thermo Scientific) at 250 °C. 
Tandem mass spectroscopy analysis was undertaken using an LTQ-Orbitrap Velos 
mass spectrometer in data-dependent acquisition mode, controlled using Xcalibur 2.1 
software (Thermo Scientific).  Survey scans were performed at 60,000 resolution (m/z 
400) in the mass range ofm/z 300 – 2000. In each duty cycle the top ten multiply 
charged ions in the LTQ linear ion trap were selected for MS/MS. Charge state filtering 
and dynamic exclusion were applied during analysis. The following fragmentation 
conditions in the LTQ were used: normalized collision energy, 40%; activation q, 0.25; 
activation time 10ms; and minimum ion selection intensity, 500 counts. All output data 
were processed and quantified in Proteome Discoverer software v1.4 (Thermo 
Scientific). Mass results were searched against the UniProt V. maris strain AB-18-032 
database (6006 entries) applying the SEQUEST algorithm.  The mass tolerance value 
was set at 10 nppm; the MS/MS tolerance value was set to be 0.8 Da. Search criteria 
included carbamidomethylation of cysteine (+57.0214) as a fixed modification and 
oxidation of methionine (+15.9949 Da) and the DMPA modification of aspartic and 
glutamic acid (+84.105 Da) as variable modifications. Mass searches included 
complete tryptic digestion, incorporating a maximum tolerance of 2 missed cleavages 
permissible. Searches were performed with the reverse database search option 
 29 
active, with all peptide data filtered to ensure a maximum false discovery rate (FDR) 
of no greater than 1%.   
2.13 Small Angle X-Ray Scattering (SAXS) Techniques  
SAXS measurements were undertaken on beamline B21 at Diamond Light Source 
(Harwell, UK) fitted with a BIOSAXS robot for automated sample loading and recovery. 
Protein samples were transferred to the 96-position sample holder of the EMBL 
BioSAXS robot. Loaded samples were auto-injected into a 1.8 mm interal diameter 
quartz capillary positioned perpendicularly to the X-ray beam. The quartz capillary was 
housed in a vacuum chamber to minimise scattering artefacts. Scattering data were 
collected using a fixed camera length (4.014 m) and energy (12.4 keV). Scattering 
images were recorded on a PILATUS 2M detector. Sample concentrations for 
scattering experiments were as follows: 1, 0.5, and 0.25 and 0.125 mg.mL-1 for 
buffered WT AbyU; 1 mg.mL-1 for buffered conjugated AbyU. Samples were exposed 
for 15s, collecting 18 frames at 20°C. Following data collection individual frames were 
sector-integrated. As a consequence of the absence concentration-dependent effects, 
all data were collected from AbyU samples at 1 mg.mL-1. Scattering from buffer only 
samples was subtracted from AbyU samples on the beam-line using SCATTER.  
Maximum intra-particle dimensions (Dmax) and particle distance distribution functions 
(p(r)) were calculated using the programme GNOM (Svergun, 1992). Radius of 
gyration (Rg) calculations were carried out using PRIMUS (Petoukhov, 2012), applying 
the Guinier approximation and were used to generate a Kratky plots. Ab initio protein 
models (13 total) were produced using DAMMIF/DAMMIN and averaged using 
DAMAVER in the ATSAS suite (Franke & Svergun, DAMMIF, a program for rapid ab-
initio shape determination in small-angle scattering. , 2009). The final model was 
superposed to the AbyU structure (PDB ID:5DYV) using SUPCOMB (Franke, et al., 
2017).  
2.14 UV/Visible Spectroscopy  
Samples were diluted in 20 mM of the corresponding buffer, and absorbance 
measurements were taken over the wavelength range λ = 200-600 nm using a 
[1] 
 30 
Lambda 25 spectrophotometer (Perkin Elmer, USA). The Beer-Lambert law was used 
to determine protein concentration, according to the following equation: 
A = ecL 
accounting for path length (L), the absorbance intensity (A280) at λ = 280 nm and the 
extinction coefficients (ε280) of 25440 M- 1cm-1 for native AbyU (Protein Calculator, 
Scripps Research Institute).  
2.15 Synchrotron Radiation Circular Dichroism (CD) Spectroscopy  
Near and far-UV circular dichroism spectroscopy was performed using Beamline B23 
running Global Works software (Olis, USA) at Diamond Light Source. Samples were 
diluted in the corresponding buffer, then scanned between λ = 180-260 nm in 1 nm 
increments with 4 second integration times. The temperature was kept constant at 
25°C, except during thermal unfolding experiments, in which case the temperature 
was incrementally increased to 95 °C using a Peltier Temperature controller 
(Quantum, USA) in 5°C increments. Prior to each scan, the temperature was allowed 
to equilibrate for five minutes. All circular dichroism data is reported in units of mean 
residue molar ellipticity (θMR). This was calculated by normalising the circular 
dichroism (ΔA) signal with respect to sample concentration (C), pathlength (L) and 
number of amino acids (N), according to the following equation: 





Where M is the average molecular weight of the protein  




2.16 Chemical Denaturation Studies 
Chemical denaturation studies were performed my monitoring the change in 
environment of the 3 tryptophan residues of AbyU. A change in fluorescence denotes 
exposure of the tryptophan residues to solvent and indicates protein unfolding.  A stock 
solution of GuHCl (6 M) was prepared in 20 mM Sodium phosphate buffer, pH 7.5, 
and serially diluted using buffer to prepare a series of solutions containing different 
concentrations of GuHCl. The mean residue ellipticities of the different solutions were 
measured at 20°C using a fluorometer at an excitation wavelength of 290 nm. 
Emission acquisition scans were from 310-400 nm. For each concentration of GuHCl, 
3 scans were taken and averaged. The free energy of unfolding at different denaturant 
concentrations (DGu) was established using the equation: 
DGu = -RTln(f/l -f) 
Where Gu = the free energy of unfolding 
R = gas constant  
T = temperature constant in Kelvin 
These values were then plotted vs. concentration of denaturant. Estimates of the free 
energy of unfolding without denaturant present (DGuH2O) were obtained by a linear 
extrapolation.  









sD = signal at maximum denatured 
X = denaturant concentration 
M = m-value 
m = cooperative unfolding constant.  
Measurements (n=3) of the catalytic activity of native AbyU were carried out in 
increasing concentrations of GuHCl to assess enzyme tolerance to denaturant. The 
reaction was allowed to equilibrate for 1 minute, and initial velocity was measured.  
2.17 Enzyme Activity Assays  
Reaction rates for the conversion of substrate to product in the presence or absence 
of native and modified AbyU were determined spectrophotometrically by monitoring 
the rate of substrate disappearance at 325 nm, employing an extinction coefficient of 
18400 M-1cm-1. The rate of the AbyU catalysed and non-catalysed reactions were 
calculated by monitoring the change in absorbance for 1 minute at substrate 
concentrations of 0, 50, 75, 100, 150 and 200 μM. A second set of reactions were 
carried out using a quartz cuvette of 1 mm pathlength, a 1 μM concentration of enzyme 
in a total volume of 400 μL. This was to investigate enzyme kinetics at higher substrate 
concentrations (100, 200, 300, 400, 500 μM) in order to saturate the enzyme active 
site and calculate enzyme parameters (kcat, Km). All assays were performed in reaction 
buffer comprising 20 mM phosphate, 150 mM NaCl, pH 7.5, at 20 °C. Preliminary 
AbyU enzyme activity assays were undertaken using an assay volume of 125 µL in 
10% acetonitrile, using a 1 cm pathlength quartz cuvette. In subsequent analyses of 
the modified AbyU catalysed reaction, a high-throughput screening method was 
employed using a UV-visible spectrometer plate reader. Low volume absorbance 
assays were carried out in a 96-well plate, over a period of 5 minutes. Readings were 
taken at 25 second intervals for substrate concentrations in the range 0, 25, 50, 75, 
100, 150, 200 and 250 μM. 7 µL of 1 µM enzyme was added to each well, which 
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contained 10% acetonitrile in a total volume of 100 µL buffer. The absorbance of each 
well solution was monitored continuously using a microplate reader by monitoring the loss 
of absorbance signal at 325 nm. The intensity values were converted to concentration 
values using the standard curve, and initial velocities for each assay were determined by 
normalizing the data to the 10% acetonitrile buffer control. A 60 mM stock solution of 
AbyU substrate was diluted 1 in 10 and dissolved in 50% acetonitrile to give a 6 mM 
working stock of substrate. This was accounted for during assay preparation to ensure 
10% acetonitrile concentration for each reaction condition. All assays were initiated by 
the addition of cold substrate (4 °C) to pre-prepared reaction mixes. The reaction 
velocities of native, cationised and conjugated enzyme at a final concentration of 1 μM 
were analysed. Controls were performed using identical assay mixes and reaction 
conditions, but either excluding enzyme, or using heat denatured native enzyme and 
heat denatured modified enzymes. Heat denatured samples were heated to 95 °C and 
checked for loss of secondary structure using CD spectrometry.  
For non-enzymatically catalysed reactions the resulting data were fitted to an equation 
of the form: 
[A] = [A0]e-kt 
Where [A] = the concentration of substrate at time t 
[A0] = the concentration of substrate at time 0 
k = the reaction rate. 









[E] = enzyme concentration 
[A] = substrate concentration at time 0 
kcat = the enzyme catalysed reaction rate  
Km = the Michaelis constant.  
All reactions were repeated in triplicate. Data fitting was performed using GraphPad 
Prism.  
2.18 Activity Assay Data Analysis 
Catalytic activities of native and modified AbyU at 25 °C were determined from mean 
average (n=3) initial reaction rates by linear regression analysis. Turnover rates 
were derived from absorbance changes at 325 nm at defined time points post 
substrate addition (averages of n=3). This was calculated by dividing substrate 
concentration (ε325=36930 M−1  cm−1) by the concentration of enzyme active sites. 
Absolute values for enzyme and substrate concentrations within assay mixes were 
calculated from constituent mass fractions. Activities were derived from 
experimentally determined initial by plotting A325 vs. time at varying substrate 
concentrations. Normalised data were fitted to an exponential function to mitigate 
variations in absorbance readings. Resulting plots of rate vs. concentration were 






Chapter 3. Results and Discussion 
3.1 Expression and Purification of AbyU 
AbyU was recombinantly over-expressed in E. coli strain BL21(DE3) and the resulting 
protein then purified using nickel affinity chromatography (Figure 3.1) followed by size 
exclusion chromatography (SEC) (Figure 3.3). SDS-PAGE analysis of fractions eluted 
from each chromatographic step demonstrated the effectiveness of the purification 
strategy employed (Figures 3.2 and 3.4), which yielded an AbyU preparation of >95% 
purity.  
 
Figure 3.1 Ni-NTA affinity purification of AbyU. A chromatogram showing the purification 





















































Figure 3.2 SDS-PAGE analysis of Ni-affinity purification of AbyU. Cell lysate generated 
from E. coli expressing recombinant His-tagged AbyU was fractionated using Ni-NTA affinity 
chromatography and the proteins in each fraction analysed by SDS-PAGE. The theoretical 
molecular weight of an AbyU monomer with an attached hexa-his tag is ~17.7kDa. The 
expected position of migration is indicated by the white asterisk.   
 
The eluted fractions correspond to the method used to purify protein. Fraction A5 
corresponds to roughly 300 mM imidazole, and the following fractions were collected 
















































Figure 3.3 Size exclusion chromatogram of purified recombinant AbyU. The 
chromatogram shows the elution profile of AbyU from a Superdex 75 10/300 column (GE 
Healthcare). The buffer used for purification was 20 mM Tris-HCl, 150 mM NaCl, pH 7.5. 2.5 
mg.mL-1 of protein was loaded onto the column. Eluted peaks were observed by monitoring 
the absorbance of the column eluent at 280 nm. A single protein species is observed eluted 































Figure 3.4 SDS-PAGE analysis of SEC column fractions. Fractions were eluted from a 
superdex S75 10/300 column. The apparent molecular weight of AbyU is ~17.7 kDa with the 
associated tag.  
Fraction B3 corresponds to roughly 55 mL column eluted, and the following fractions 
were collected at 1 mL intervals. Fraction B7 corresponds to the apex of the elution 
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3.2 Protein Quantitation  
Fractions containing AbyU, recovered following SEC purification, were pooled and the 
concentration of protein in the pooled fractions was determined. This was done by 
measuring the absorbance of the solution at 280 nm, or by BCA or Bradford assay, 





Figure 3.5 BCA assay standard curve used to estimate protein concentration. Estimated 
based on the absorbance of the protein standard BSA measured at 562 nm. The plot was 






Figure 3.6 Bradford assay standard curve for measurement of protein concentration. 
The plot was generated using the formula y = mx + c, n=3.  
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The total yield from the protein preparation was ~15 mg.mL-1. The results of the 
protein preparation using absorbance at 280 nm to estimate the native AbyU protein 
yield were similar to that of the BCA and Bradford assays. Following cationisation 
and conjugation, the protein might precipitate due to the harsh reaction conditions of 
the modification process. Therefore, the yield of native AbyU during preparation is 
likely to be higher than the cationised and conjugated proteins.  
The absorbance at 280 nm could not be used following cationisation and conjugation 
due to the surfactant polymer interfering with the signal at 280 nm. This is because 
the polymer also absorbs at 280 nm, so the total reading will be much higher than 
the amount of protein present in the samples. The BCA and Bradford assays were 
therefore the best techniques available to estimate protein concentration after 











3.3 Validating Cationisation  
Following purification and quantitation of recombinant AbyU, the cationisation 
efficiency of DMPA-coupling to the enzyme was determined using two techniques; 1) 
zeta potentiometry and 2) matrix-assisted laser desorption ionization time-of-flight 
(MALDI-TOF) mass spectrometry. The two-step bioconjugation was achieved by the 
covalent coupling of N,N′-dimethyl-1,3-propanediamine (DMPA) to the side chains of 
acidic amino acids within AbyU, to form the cationised protein. These residues were 
in turn electrostatically conjugated to the anionic polymer–surfactant glycolic acid 
ethoxylate 4-nonylphenyl ether (H19C9-Ph-O-(CH2CH2O)40-CH2-COO-) to produce 
hybrid protein-surfactant complexes. Zeta potential measurements confirmed that 
cationisation had yielded an AbyU derivative with a predominately positively charged 
surface, which had been neutralised following surfactant conjugation (Figure 3.7). The 
efficiency of cationisation of was determined using mass spectrometry. Analysis of 
these data were consistent with the addition of ~20 molecules of DMPA (Figure 3.8). 
 
Figure 3.7 Zeta potential spectrometry of modified AbyU enzymes. n=5, where n=number 
of measurements. The plot is a mean average trace. The zeta potential changed from -3.34 
mV ± 0.3 for native AbyU to + 13.67 mV ± 0.7 for [C-AbyU], consistent with the switching of 
the polypeptide’s surface potential from negative to positive. The zeta potential for [C-AbyU][S] 
was + 2.85 mV ± 0.8, which shows that the positive charge on the surface of [C-AbyU] 
decreased following conjugation. 
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~15.6 kDa 






Figure 3.8 Mass spectrometry of AbyU and [C-AbyU]. Mass-to-charge (m/z) spectrum of 
AbyU and [C-AbyU] generated by MALDI-TOF. The natural AbyU, tag-cleaved molecular 
weight ~15.6 kDa, is shown to be a monomer under MALDI-TOF conditions. However, in 
solution AbyU forms a dimer. A mass increase from 15.6 kDa to 17.7 kDa is observed after 
cationisation. Two species of [C-AbyU] are seen, appearing at ~17.7 kDa and ~35.5 kDa. It 
may be that the conditions of MALDI-TOF promotes dimerisation of the cationised protein, 
which could explain the two peaks seen. 
Mass spectrometry experiments identified a subunit molecular weight of 15.6 kDa for 
native (un-tagged) AbyU and 17.7 kDa for [C-AbyU]. This mass increase equates to 
~20 DMPA (MW ~100 Da) molecules/protein monomer, and hence cationisation of 20 







3.4 Identification of Cationised Sites  
Tryptic digests were performed on [N-AbyU] and [C-AbyU] to determine which amino 
acid residues had been modified by DMPA. The enzyme trypsin is used to digest 
protein into smaller peptides, which can then be analysed by matrix-assisted laser 
desorption ionization mass spectrometry (MALDI-MS), enabling quantitation their 
mass and establishment of their identity. Trypsin preferentially cleaves lysine and 
arginine residues in the N-to C-terminal direction. There are 13 cleavage sites in the 
AbyU sequence, releasing 14 peptides of varying lengths. This type of analysis is 
useful as it gives explicit information on which side chains are being modified, aided 
by the differences between the peptide mass fingerprints of [N-AbyU] and [C-AbyU].  
The resulting changes in masses of the individual peptide fragments were able to 
elucidate which side chains DMPA attached to (Table 3.4).  
An increase in peptide mass of ~84.05 Da is seen following cationisation (Table 3.4) 
at a specific site, which can be attributed to DMPA addition (+84.105 Da) to acidic 
residues. Retention times of modified fragments were shorter than native peptide 
fragments, which can be explained by the increase in positive charge caused by 
DMPA, as retention time has been shown to decrease dramatically with an increase 
in the number of positive charges within the peptide fragments (Mant & Hodges, 2006). 
This is evidenced by peptides that were not modified in [C-AbyU], which retain the 
same masses and retention times as in [N-AbyU]. The LCMS analysis revealed that 
the modifications occurred mainly in the beta motif and turns (Figure 3.9). It is 
expected that the chains being modified would be those that are solvent accessible, 



















LETRPQALLIKVPTEIVVK 5-23 1 0  2147.320 2147.318 92.17 92.35 
 
VVddVdVAAPAVGQVGK 24-40 0 3 
D3 (DMPA) 1638.874 1722.977 75.83 57.58 
D4 (DMPA) 1638.874 1722.977 75.83 57.34 
D6 (DMPA) 1638.874 1722.978 75.83 58.79 
FDDeLYdeAGAQIGTSSGNFR 41-61 0 3 
E4 (DMPA) 2292.005 2376.116 105.49 86.79 
D7 (DMPA) 2292.005 2376.110 105.47 86.77 
E8 (DMPA) 2292.005 2376.110 105.47 86.77 
TSKWVFYPATGVSGR 100-114 1 0  1655.856 1655.856 79.08 79.46 
 
SAEARILLGe 132-141 1 1 E10 (DMPA) 1058.585 1142.692 65.96 46.56 
Table 3.1 Modifications to AbyU peptide sequences. Following cationisation, DMPA 











Figure 3.9 Protein sequence of AbyU showing secondary structure. DMPA modification 
sites are highlighted in yellow and capping loop residues are shaded in pink.  
The peptide sequence, IEYVRPTDGGLLTYYQEDITLSDGVIHAEGWADFNDVR, was 
unable to be analysed by MALDI-TOF, as the ionised fragment was too large to be 
accelerated towards the mass spectrometer detector. This peptide equates to a region 
on the outside of the b-barrel where DMPA modification is expected to occur, therefore 
the proportion of DMPA-modified sites reported by the digest may not accurately 
reflect the true amount of DMPA coupling to aspartate and glutamate residues of 
AbyU. Since trypsin is unable to cleave this peptide into smaller fragments, a future 
experiment could use other proteases, such as pepsin (pH>2, 14 cleavage sites) or 
proteinase K (22 cleavage sites), to digest the sequence. However, this analysis 
reveals that DMPA modification is concentrated in flexible loop areas and on the 
outside of the barrel (Figure 3.10), being particularly evident on the capping loop. This 
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Figure 3.10 Location of the DMPA modification sites on AbyU. (A) Side-on view of 
modification sites in AbyU. (B) Top-down view of AbyU. DMPA-modified aspartates are shown 
in blue, modified glutamates are shown in orange. Yellow residues and red residues indicate 
unmodified glutamate and aspartate residues, respectively.   
There are 3 amino acids (E19, D43, E78) inside the AbyU b-barrel core which could 
potentially react with DMPA (Figure 3.10). The digest revealed that these residues 
were not modified, which suggests that there is no DMPA addition within the enzyme 
active site. This is expected, as these residues are highly protected from solvent 
exposure through the action of the capping loop, making it unlikely that DMPA coupling 
would occur in this region. The data demonstrates that the 3 acidic residues in the 
enzyme active site were not modified and identifies those on the outside of the enzyme 






3.5 Validating Conjugation  
SAXS and NATIVE-PAGE analysis were used to investigate conjugation success. 
SAXS is useful as it can provide nanoscale structural information about biomolecules 
(>30 kDa), describing parameters which include overall shape, particle size, samples 
homogeneity and surface to volume ratio (Hura, Menon, Hammel, Rambo, & Poole, 
2009). X-rays are shone through a solution of protein, which scatters the incoming X-
rays to give a scattering pattern, which is subsequently recorded on a detector (Figure 
3.11). An electron density map is created based on the contrast between the protein 
and solvent, according to the equation Dr(r) = r(r) protein - rsolvent, where r 
describes the distance distribution function between particles either in the protein or 
in the solvent. The p(r) function averages the distance vectors within the particles from 





Figure 3.11 Principle of Small-angle X-ray scattering. Taken from Polymer Journal (Nozue, 
Shinohara, & Amemiya, 2007) in which the scatter signal of the buffer solution is background 
subtracted from the scatter signal of the protein solution.  
SAXS can provide evidence for a protein’s oligomeric state in solution, provide a low-
resolution structural model describing shape (e.g. globular, ellipsoidal) and identify 
whether polypeptides are able to interact to form complexes. Significantly, SAXS data 
can propose a 3D representation of the protein by constructing an electron density 
envelope and fitting a high-resolution image of the protein structure within the 









Figure 3.12 Calculation of protein structure using SAXS. Using the p(r) function, which 
encompases a set of all distance vectors within the molecule, relating scatter intensity (I) to q 
(the scattering vector). The data at small values of q correlates to large distance vectors within 
the particles. The separate peaks indicate a poly-dispersed sample, with higher molecular 
weight populations seen at lower q values, given in inverse angstroms (Å-1). The graph was 
generated using the program ScÅtter.  
The radius of gyration (Rg) measured in reciprocal space is called the Guinier fit and 
describes the distribution of mass around a particle’s centre of inertia. A Guinier 
analysis produces a straight line that slopes downwards; where Rg is the slope of that 
line. There is an approximation in which a globular particle will show a straight-line 
relationship in the low q region, which was observed for both native AbyU and [C-
AbyU][S] (Figure 3.13). The normal distribution of the residuals along the straight line 
for [N-AbyU] and [C-AbyU][S] indicate that the protein is behaving as expected, and 
shows that the calculated fit is good, allowing accurate calculation of SAXS 
parameters.  A deviation from linearity is indicative of protein aggregation.  
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Figure 3.13 Guinier linear approximation and Kratky plots used to assess structure and 
size of [N-AbyU] and [C-AbyU][S]. The Guinier fitting of the raw data is plotted as q2 Å-2 vs. 
the scattering intensity (ln[I(q)]). The red lines indicate the trendline, the individual data points 
from the beamline are represented as circles. Convergence of the p(r) function to the x axis in 
the Kratky plot indicates the extent of folded protein. Buffer subtraction was carried out to 
determine the scattering effect from the particles only. Data fitted by Carl Marsh using the 
program ScÅtter.  
Conjugated AbyU  Native AbyU 
 50 
Protein folding was analysed using Kratky plots, which were generated from the p(r) 
function. The function exhibited a bell-shaped peak at low q for [N-AbyU] and [C-
AbyU][S], that converged smoothly to the x axis, signifying well-folded, globular protein 
(Figure 3.13). Significantly, the plot will not approach the q axis if the protein has 
pronounced flexibility or if it is unfolded (Figure 3.14). Interestingly, the native enzyme 
appears to converge at a lower q value and has less features of a flexible protein. A 
reason for this could be that the surfactant has introduced non-native flexibility to the 
protein, by creating new contacts to and around the protein structure. The extended 
tails, observed as a departure from the q axis and a lack of fit of the residuals observed 
in the (log [I(q)]) vs. q plot, suggest that there is a large object adversely affecting the 
data, which is possibly caused by the formation of AbyU tetramers. This could be a 
valid explanation as the NATIVE-PAGE analysis of native AbyU found that the enzyme 





Figure 3.14 Kratky plot analysis, which informs on protein globularity and flexibility. 
Taken from (Stanford, 2017).  
The p(r) function estimates the particle volume (given in cubic angstroms) and the 
dmax, which is the maximum dimension of the particles. Since the [N-AbyU] and [C-
AbyU][S] samples are polydispersed, these calculated values are a mean average of 
the ensemble of particles in the sample, therefore this can generate a ‘fuzzy cloud’ 
density, which is likely to be much bigger than the actual MW (Stanford, 2017), and 
give a larger volume than would be expected. This could account for the large MW 
and total volume for the protein samples reported by the analysis. [C-AbyU][S] was 
approximately 4x the volume of the native protein (Table 3.2), which indicates 
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successful surfactant conjugation, as this would account for the greater dimensions of 
[C-AbyU][S] compared to [N-AbyU]. The polymer surfactant IGEPAL-890 (MW ~1,982 
Da) is expected to conjugate to the 37 basic residue sites on AbyU, which will result 
in a molecular weight of ~ 91, 074 Da (= 37 ´ 1,982 + 17, 700), assuming 100% 
conjugation efficiency. This is similar to the molecular weight increase reported by the 
SAXS analysis (Table 3.2), and provides evidence for the addition of 37 surfactant 
molecules to the basic residues of AbyU.   
 
 Conjugated AbyU Native AbyU 




Volume (Å3) ~160,000 ~42,000 
Molecular Weight (Da) ~100, 548  ~30,687 
Table 3.2 Summary of SAXS parameters. The dmax is the longest distance in the particle, 
it is derived from the p(r) function estimates the fit of the data to the p(r) function. The 
approximate molecular weight of the particles is calculated by diving the volume (given in cubic 
Å) from the straight-line plateau by the density of protein (an approximation of 1.7).  
Additional evidence was obtained from NATIVE-PAGE analysis of the protein samples 
under investigation. Samples were loaded side by side to aid discrimination between 
modified and unmodified samples (Figure 3.15). [C-AbyU][S] yielded a spectrum of 
species of different masses, suggesting that the protein-polymer had aggregated to 
give a range of species. This may indicate surfactant ‘stickiness’. In contrast, 
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unmodified his-tagged native AbyU migrated with a mass equivalent to 66 kDa, an 
apparent molecular mass of a quaternary species (a dimer of dimers). No monomeric 
(tagged MW ~17 kDa) AbyU was detected on the gels. This suggests that stable AbyU 
dimers associate in solution to form tetramers. These results provide further indication 








Figure 3.15 NATIVE-PAGE analysis of purified AbyU samples. The AbyU preparations 
were diluted to 1 mg. mL-1 to achieve appropriate protein loads to visualise the bands. A 
NativeMark Unstained Protein Standard (ThermoFisher) molecular weight marker was used. 
Electrophoresis employed 8% polyacrylamide gels. Samples were visualised using 
Coomassie blue staining. The asterisk indicates the migration position of the native His-tagged 
AbyU, which was ~66 kDa and is roughly the size of an AbyU tetramer.   
The NATIVE-PAGE results are in agreement with the SAXS analysis and are 
compelling evidence that protein modification has successfully yielded protein-
polymer bioconjugates. Following verification of successful conjugation, 
characterisation of the modified AbyU enzyme was performed and benchmarked 




































3.6 Determining Stoichiometry of Surfactant Conjugation 
A standard curve of surfactant absorption was produced in order to estimate the 
extinction coefficient of the surfactant (Figure 3.16). The absorbance was measured 






Figure 3.16 Standard curve used to estimate molar absorption coefficient (e) of the 
surfactant. The absorbance was measured at 280 nm at different concentrations of 
surfactant. Using the Beer-Lambert law (equation 1), the gradient of the straight line enables 
estimation the molar absorption extinction coefficient of the surfactant. In this case, e = 1595.1 
L.mol-1cm-1.  
The stoichiometry of surfactant conjugation was determined using an equation of the 
form: 
𝐴𝑏𝑠*+!E𝐴𝑏𝑦𝑈,-./H = 	𝐴𝑏𝑠*+![𝐴𝑏𝑦𝑈0#$123] +	𝐴𝑏𝑠*+![𝑆𝑢𝑟𝑓𝑎𝑐𝑡𝑎𝑛𝑡]	 
A 0.1 mg.mL-1 sample of [C-AbyU][S] absorbed 0.78 units at 280 nm (Figure 3.17). A 







Figure 3.17 Absorption spectra of [C-AbyU][S] over the wavelength range 0 – 600 nm. 
A peak is visible at 280 nm. This absorbance value was used to determine 𝐴𝑏𝑠RS4E𝐴𝑏𝑦𝑈TUVWH.  
Following the equation; 0.78 = 0.23 + 𝑥 
𝑥 =	0.55 
Inputting the calculated absorbance value into the Beer-Lambert equation to solve for 





 = 3.44 ´ 10-4 mol.L-1  
Moles of surfactant = 3.44 ´ 10-4 mol.L-1 ´ 100 µL = 3.44 10-8  mol 
Moles of AbyU = (!.7	%<.%=	×	7!!	µ=	)
7??@!	<.%AB12
 = 5.6 ´ 10-10 mol 
Moles of surfactant added per mole of AbyU = C.@	´	7!
1Y	DEF
6.G	´	7!12Z	DEF
 = 60  
This shows that for every mole of AbyU, 60 surfactant chains are conjugated to the 
protein. 














0.1 mg.mL-1 AbyU Surfactant Conjuagted Absorbance 
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3.7 Chemical Denaturation Studies to Evaluate Enzyme Tolerance 
Unfolding characterisation of AbyU in ‘harsh’ reaction conditions were performed to 
assess enzyme tolerance and catalytic performance. The native enzyme was 
irreversibly unfolded using the denaturant guanidinium hydrochloride (GuHCl) in order 
to generate a reference of attributes for comparison with the modified enzyme. The 
tertiary structure composition of AbyU as a function of denaturant concentration was 
monitored using fluorescence spectroscopy. This technique exploits the intrinsic 
fluorescence of the tryptophan residues in AbyU. Protein stability was found to 
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Figure 3.18 Emission spectra of (A) Native and (B) Conjugated AbyU in the presence of 
up to 4 M GuHCl denaturant. Scans were taken across the wavelengths 300 nm – 400 nm. 
Each protein exhibited a well-defined peak ~350 nm. This is due to the tryptophan 
fluorescence signal, a decrease in which corresponds to a loss of protein secondary structure.  
 
 
Figure 3.19 Chemical unfolding profiles of [N-AbyU], [C-AbyU] and [C-AbyU][S] in 
GuHCl.  
Wavelength (nm) 






















Figure 3.20 Spectroscopic scan of surfactant emission at 350 nm. This was background 
subtracted from the emission spectra of [C-AbyU][S].  
Native AbyU was found to retain tertiary structure in the presence of denaturant at 
concentrations up to 3 M (Figure 3.18). GuHCl-induced unfolding shows a cooperative 
transition of the native protein and reveals that the protein unfolds via a two-state 
(native ↔ unfolded) mechanism. Conjugated AbyU exhibits an increased tolerance to 
higher concentrations of denaturant. This could be explained by the addition of the 
surfactant corona, which may physically protect the protein from exposure to 
denaturant. Together, this could account for the non-cooperative behaviour exhibited 
by [C-AbyU][S], as the surfactant corona may be acting to maintain protein structure, 
until a critical proportion of native contacts are lost. [C-AbyU] is rapidly unfolded at 
lower concentrations (2 M) of denaturant (Figure 3.19). This could be due to a change 
in the charge of the side groups, or due to the non-catastrophic conformational 
changes made to the enzyme’s b-barrel structure during the process of cationisation 
that has left the tryptophan residues, normally protected on the inside of the protein, 
exposed to denaturant. This may be evaluated by performing the experiment in the 
presence of tryptophan only. However, it should be noted that tryptophan (W) is not 
an ideal reporter as its fluorescence signal changes upon solvent exposure. For these 
reasons, it was necessary to carry out further enzyme characterisation, as is detailed 
below.   
 
Surfactant Only Unfolding as a Function of [GuHCl] at 350 nm 
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3.8 Circular Dichroism Spectroscopy  
A number of spectroscopic and binding studies were performed in an effort to 
investigate the structure and function of modified AbyU polypeptides. The thermal 
unfolding behaviour of AbyU was examined using circular dichroism (CD) 
spectroscopy, a technique that reports on protein secondary structure (far-UV CD 200-
250 nm) and tertiary structure (near-UV CD 260-300 nm). CD analyses revealed that 
the introduced chemical modifications had minimal impact on the secondary and 
tertiary structure of AbyU at 25 °C, with peaks in the CD spectra characteristic of a 
predominantly β-structure observed (Figure 3.21).  The far-UV CD spectrum of AbyU 
reveals a minima at ~220 nm, which is typical of proteins with high beta-strand content, 
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Figure 3.21 Structural characterisation of the protein complexes. CD spectroscopy was 
used to analyse the structure of native AbyU and [C-AbyU][S]. (A) Near-UV CD of [N-AbyU]  
and (B) near-UV CD  of [C-AbyU][S] in molar residue ellipticies (MRE). Superimposed traces 
indicate retention of native secondary and tertiary structure, at 25°C (blue trace) and a loss of 
b-barrel structure at ~225 nm at 95°C (red trace). The peaks observed at 180 nm were present 
in both samples, indicating that the conjugated enzyme retained the predominantly b-barrel 
secondary structure of native AbyU.  
Thermal denaturation of AbyU reveals no loss in secondary structure at temperatures 
up to 65 °C. Above this threshold, however, the enzyme undergoes a rapid, non-
reversible, unfolding. This was confirmed by carrying out thermal refolding 
experiments on native and conjugated AbyU, incrementally decreasing the 
temperature from 95 °C to 25 °C. Neither enzyme recovered the folded state after 


























































Figure 3.22 Structural characterisation of thermally refolded AbyU. Far-UV CD was used 
to analyse protein secondary structure of (A) N-AbyU] and (B) [C-AbyU][S] upon cooling back 
down to 25 °C. No refolding was seen after heating to 95 °C in either the native or conjugated 
samples. The blue trace indicates 25°C and the red trace 95°C.  
a   
B  Conjugated AbyU Thermal Refold 


































































A  Native AbyU Thermal Refold 
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Thermal denaturation melting curves (λ=220 nm) showed progressive decreases in 
stabilities (Figure 3.23). [C-AbyU][S] exhibited a half denaturation temperature of 
70 °C, compared with 62 °C for [N-AbyU]. This represents a modest increase in 
thermal stability due to conjugation and suggests that modification has improved the 
structural stability of the enzyme at higher temperatures. A reason for this could be 
that the surfactant corona has increased the stability of amino acid contacts within the 











Figure 3.23 Temperature denaturation profiles of AbyU. (A) [N-AbyU] and (B) [C-AbyU][S] 
plots were fitted to sigmoidal curves (black lines). The half denaturation temperature of native 
AbyU and conjugated AbyU were calculated to be 61.5 °C and 70°C, respectively. 
a  Thermal Unfolding of Native AbyU at 225 nm 


















Thermal Unfolding of Conjugated AbyU At 225 nm 
V50 = 70oC
R2 = 0.965  
B  Thermal Unfolding of Conjugated AbyU at 225 nm 


















Thermal Unfolding of Native AbyU At 225 nm 
V50 = 62oC
R2 = 0.899  
A  Thermal Unfolding of Native AbyU at 225 nm 






















Tm = 61.5 °C  ± 0.3 °C   
Tm = 70 °C  ± 0.2 °C   
Tm = 61.5 °C  ± 0.3 °C   
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3.9 Enzyme Activity Assays  
To complement folding studies of native and modified AbyU, the catalytic activity of 
these proteins was investigated. This was achieved initially by monitoring the 
conversion of a diketone synthetic analogue of AbyU’s natural substrate to its spiro-
cyclic product by LCMS as previously reported (Figure 3.24; Byrne et al., 2016). AbyU 
accepts a synthesised OMe-substituted substrate analogue and converts it to the 
corresponding product. The methyl group protects the substrate, to an extent, from 
auto-cyclisation. Enzyme independent cyclisation of this compound was detected. As 
a consequence, this background reaction was subtracted from all readings. This rate 








Figure 3.24 Mass spectra of AbyU substrate and AbyU catalysed reaction products. 
Positive ion mode ESI MS of the substrate and product, recovered from AbyU catalyzed [4+2] 
cycloaddition reactions. Product masses are consistent with the structure with m/z of [M + Na]+ 








LC-MS based assays, that involved the quantitation of the spiro-cyclic reaction 
product, were used to determine the relative activities of native and modified AbyU 
(Figure 3.26). Comparative analysis of the results demonstrated that the enzyme-
catalysed substrate turnover rates were faster than that of substrate alone. 
Surprisingly, the rates of [C-AbyU] and [C-AbyU][S] were faster than for the native 
enzyme. These data give compelling support for an enhancement in the rate of AbyU 
catalysed [4+2] cycloaddition when the enzyme has undergone modification, an 










Figure 3.25 Native and modified AbyU activity assays. LC-MS assays measuring rate of 
disappearance of substrate at 325 nm after 1 min, 5 min or 30 min incubations with AbyU. 10 
mM substrate was incubated in the presence or absence of 280 μM AbyU at 25 °C. The error 
bars are mean average and standard deviations based on abundance of substrate at 325 nm 
from 3 separate reactions.  
1 min Incubation   5 min Incubation 
  
 64 
3.10 Elucidation of Enzyme Reaction Rates 
To determine the effects of modification on enzyme catalytic activity, initial velocities 
of the AbyU catalysed and non-catalysed reactions were measured 
spectrophotometrically at 325 nm. Conjugated enzyme turnover rates were found to 
be significantly faster than for the native enzyme, suggesting that modification had 






Figure 3.26 The rate of substrate disappearance at 325 nm catalysed by [N-AbyU] and 
[C-AbyU][S]. Measurements were taken at 0.01 min intervals during the reactions and fitted 
to a standard exponential decay. The bold lines indicate the trendline, and lighter shaded 
areas indicate error bars (standard errors of the mean), averaged from n=3. 
Next, a complete steady state kinetic characterisation was performed (Figure 3.28 and 
Table 3.3). Substrate turnover per enzyme active site is increased following 
cationisation and conjugation, as is indicated by enhancements in kcat. An increase in 
Km is also observed, which could be explained by the attachment of surfactant polymer 
to the capping loop of the enzyme, as exemplified by the high proportion of cationised 
sites in this area. This could preclude substrate from entering and exiting the catalytic 
site. This would decrease enzyme affinity for the substrate and the enzyme would 
require a higher concentration of substrate to achieve maximum turnover rate (Berg, 
Tymoczko, & Stryer, 2002). Unfolded conjugated and unfolded native enzymes were 
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found to have activities equivalent to substrate only, whilst the active samples of 
modified enzyme are unequivocally higher.  
 
Figure 3.27. Kinetic analysis of non-enzymatically catalysed and enzymatically 
catalysed reactions, at varying concentrations of substrate. Substrate turnover was 
monitored spectrophotometrically at 325 nm. Results were obtained in triplicate and the 
standard error from the mean calculated. The difference in rate between the enzyme catalysed 





















 [N-AbyU] [C-AbyU] [C-AbyU][S] 
Km (µM) 41 ± 15 99 ± 19 124 ± 22 
 
kcat (min-1) 357 ± 40 420 ± 31 751 ± 72 
 
kcat/Km (µM. min-1) 8.5 ± 1.5 4.2 ± 0.8 6.0 ± 1.2 


















Chapter 4. Discussion 
In this study, a protein modification technique has been applied to the natural Diels-
Alderase AbyU. It was hoped that this method could be used to improve the tolerance 
of the enzyme to ‘harsh’ reaction conditions and hence improve its suitability for use 
in industrial processes. The work presented herein demonstrates the tractability of this 
approach and lays the groundwork for its future application to other enzyme targets. 
AbyU was found to be highly amenable to bioconjugation and satisfactory yields of 
modified enzyme conjugates could be recovered. Total loss of protein structural 
integrity following bioconjugation is common, as the harshness of the process may 
initiate enzyme unfolding. This is an often-reported negative consequence of protein 
modification by cationisation and surfactant conjugation. A 24-hour incubation at pH 
6.0 typically with high titres of DMPA and EDC will effectively ‘attack’ the protein target, 
causing polypeptide destabilisation and aggregation. Some optimisation of 
conjugation conditions was required during this study, however, this was to be 
expected given the invasive nature of the technique.  
Analytical methods were successfully applied to elucidate the degree and location of 
modifications on the enzyme, revealing that these were restricted to acidic residues 
located in the loop regions of AbyU and the outer surface of the protein. No conjugation 
was observed for residues that reside within the enzyme active site, which gave 
encouragement that AbyU may retain catalytic activity following treatment.  
Circular dichroism and fluorescence spectroscopy have been applied to examine the 
secondary structure composition of the modified polypeptides and their susceptibility 
to thermal and chemical denaturation as compared to native AbyU. These studies 
found that surfactant conjugated [C-AbyU][S] was the most stable form of the enzyme, 
with an improved tolerance to high temperature and denaturants. Native AbyU has a 
Tm of 61.5 °C  ± 0.3 °C and a GuHCl denaturation midpoint of 2 M, whereas 
conjugated AbyU has a Tm of 70 °C ± 0.2 °C and a GuHCl denaturation midpoint of 3 
M. This could be suggestive that the modification process has conferred enhanced 
stability to the enzyme, as the surfactant may be reinforcing the structural integrity of 
the protein structure. The improvements in stability of AbyU were modest, though 
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significant, as the degree of enhancement in protein stability will be target dependent. 
Proteins with a higher percentage of modifiable amino acids will be subject to greater 
conjugation and consequently may exhibit better improvements in their tolerance to 
denaturants and high temperature. 
Kinetic characterisation of AbyU conjugates demonstrated that these modified 
enzymes retain catalytic function, though exhibit significant changes in their steady-
state kinetic parameters. This is perhaps unsurprising given the size and extent of the 
modifications that have been performed. MALDI-MS studies demonstrated the 
presence of modifications in the active site capping loop of AbyU. The flexibility of this 
loop is known to be of importance in mediating substrate entry and product exit from 
the enzyme active site. Conjugation in this region is likely to have significant impact 
on catalysis and may account for the observed changes in kinetic parameters. For 
example, should the flexibility of this loop be impaired, or access to the active site 
restricted, this may limit the catalytic competency of the enzyme. There are also 
potential effects arising from distal conformational changes within the barrel fold of 
AbyU resulting from bioconjugation that may influence the conformational dynamics 
of the enzyme.  
The introduction of the conjugate corona around the enzyme may also have an effect 
on the attraction or repulsion of substrate molecules. This will have an impact on 
substrate availability to the enzyme active site. The increased Km observed for AbyU 
bioconjugates implies that the enzyme has a reduced affinity for substrate. This would 
be consistent with the largely hydrophobic substrate interacting with the hydrophobic 
tails of the surfactant, reducing the rate of transfer to the enzyme active site. Therefore, 
it seems that, although improvements to Kcat were observed, the concomitant increase 
in Km suggests that the overall enzyme kinetics of the conjugated protein has remained 
similar to that of the native. Suggesting that conjugation may not confer enhanced 
enzyme kinetics, but that it does not impair them either, as might be expected following 
harsh modification processes.   
The SAXS analyses reported herein suggest that conjugation results in a significant 
enhancement in the hydrodynamic radius of AbyU. Whilst this does show that the 
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enzyme has increased in mass and is encouraging to the hypothesis that the protein 
has undergone modification, it is difficult to be certain whether conjugation to the 
desired surfactant polymer has been undoubtedly successful without more detailed 
structural information about the nature of the polymer corona.    
Conjugated variants of AbyU showed no reduction in solubility in aqueous solvent. 
This was unexpected, given the hydrophobic nature of the polymer surfactant used, 
however, similar results have been reported by others who have generated equivalent 
conjugates of eGPF (Armstrong et al., 2015). Both AbyU and eGFP are inherently 
stable proteins with high solubilities. The latent physio-chemical properties of the 
conjugated target proteins may be a factor in ensuring compatibility with aqueous 
systems and this could be readily tested by applying our conjugation method to 
inherently less stable polypeptides.    
The benefits of the process outlined in this thesis are that it creates proteins with 
advantageous properties, such as retained catalytic activity and modestly improved 
thermal stability without any requirement to alter the primary amino acid sequence of 
the target protein. For this reason, the approach may have wide-ranging use in the 
modulation of protein function and specifically as a method to improve the compatibility 
of proteins with non-aqueous based solvent systems. In a complimentary study 
conducted in Bristol (Marsh et al., unpublished) it was shown that this treatment 
significantly improved the kinetic behaviour of AbyU for its cognate substrate in organic 
solvent systems, such as those commonly employed in process chemistry. Exploration 
of the solvent preferences of AbyU conjugates is a major focus for future research 
activity. Another future direction that will be explored is optimisation of surfactant 
choice. This will involve kinetic analysis of AbyU conjugated to different polymers and 
studying the resultant catalytic effects. Different surfactants may define enzyme 
function in different solvent systems, which will in turn greatly influence key aspects of 
protein stability and folding, resulting in thermodynamic and kinetic effects.  
The conjugated enzyme is highly heterogeneous due to the dynamic nature of the 
corona. However, valuable structural information could be acquired using techniques 
that are tolerant of dynamic protein systems. Elucidation of an NMR structure of AbyU 
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is almost complete and consequently this may be the favoured method for structural 
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